These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hyperhomocysteinemia and cardiovascular disease in animal model. Azad MAK; Huang P; Liu G; Ren W; Teklebrh T; Yan W; Zhou X; Yin Y Amino Acids; 2018 Jan; 50(1):3-9. PubMed ID: 29018979 [TBL] [Abstract][Full Text] [Related]
4. [Hyperhomocysteinemia and the disturbance of haemostasis--facts and mythes]. Malinowska J; Nowak P; Olas B Pol Merkur Lekarski; 2009 Nov; 27(161):413-8. PubMed ID: 19999808 [TBL] [Abstract][Full Text] [Related]
5. [Homocysteine. The cardiovascular risk factor of the next millennium?]. Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543 [TBL] [Abstract][Full Text] [Related]
6. New cardiovascular risk factors: homocysteine and vitamins involved in homocysteine metabolism. De Caterina R; Zampolli A; Madonna R; Fioretti P; Vanuzzo D Ital Heart J; 2004 Jun; 5 Suppl 6():19S-24S. PubMed ID: 15185912 [TBL] [Abstract][Full Text] [Related]
7. [Homocysteine and hyperhomocysteinemia]. Laskowska-Klita T Pol Merkur Lekarski; 2001 Mar; 10(57):135-7. PubMed ID: 11398509 [TBL] [Abstract][Full Text] [Related]
8. Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link? Paganelli F; Mottola G; Fromonot J; Marlinge M; Deharo P; Guieu R; Ruf J Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567540 [TBL] [Abstract][Full Text] [Related]
9. Fitting homocysteine to disease models, as well as adjusting the models to the disease. Luft FC J Mol Med (Berl); 2015 Jun; 93(6):585-7. PubMed ID: 25952147 [No Abstract] [Full Text] [Related]
10. Adenosine-the missing link to understanding homocysteine pathogenicity or more smoke on the horizon? Deussen A Cardiovasc Res; 2003 Aug; 59(2):259-61. PubMed ID: 12909306 [No Abstract] [Full Text] [Related]
11. Homocysteine and oxidative stress. Perna AF; Ingrosso D; De Santo NG Amino Acids; 2003 Dec; 25(3-4):409-17. PubMed ID: 14661100 [TBL] [Abstract][Full Text] [Related]
13. The current status of homocysteine as a risk factor for cardiovascular disease: a mini review. Chrysant SG; Chrysant GS Expert Rev Cardiovasc Ther; 2018 Aug; 16(8):559-565. PubMed ID: 29979619 [TBL] [Abstract][Full Text] [Related]
14. [Homocysteine--new risk factor for progression of atherosclerosis and its complications]. Brzósko S; Hryszko T; Małyszko J; Myśliwiec M Pol Merkur Lekarski; 2001 Jan; 10(55):56-9. PubMed ID: 11320555 [TBL] [Abstract][Full Text] [Related]
15. [Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor]. Caramia G; Belardinelli R Monaldi Arch Chest Dis; 2006 Dec; 66(4):275-85. PubMed ID: 17312847 [TBL] [Abstract][Full Text] [Related]
19. Roles of homocysteine in cell metabolism: old and new functions. Medina M; Urdiales JL; Amores-Sánchez MI Eur J Biochem; 2001 Jul; 268(14):3871-82. PubMed ID: 11453979 [TBL] [Abstract][Full Text] [Related]
20. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M; Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]